It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: whereislogic
a reply to: Grimpachi
All the usual government and Big Pharma controlled media channels were immediately promoting the NEJM publication you didn't link (for which you linked a related news article), quite heavily, as if their news articles were already ready to go; it was hard to miss. ...
Babak Javid
Gotta love the Press release before the data published trend in Covid-times!!
Hakim Dehbi
A concerning trend!
originally posted by: whereislogic
Yes, I noticed that as well, if you look at the Twitter post it says: "to be published @NEJM later today", yet below it are already a bunch of press releases with titles like "Hydroxychloroquine, a drug promoted by Trump, failed to prevent healthy people from getting COVID-19 in trial" and "Hydroxychloroquine does not prevent COVID-19 infection if exposed, study says".
Source: Eric Topol op Twitter: "A randomized, placebo controlled trial of hydroxychloroquine for prevention of #COVID19 shows lack of efficacy ...
QAnon, MD, PhD
"The study was conducted in an unusual way: over the internet, without patients being seen by study doctors"
Yep, that was my biggest gripe in my previous commentary about it. How can we know these are even real people reporting honestly and accurately? How can we know this electronic data wasn't tampered with by outside influences with a motive to do so (Big Pharma)? Or tampered with by inside sources with a similar motive of wanting to cover their own asses for that matter?
Jaspreet S Photography
Indian study wasn't done on Internet but health care workers were taking it. they said it reduces viral load compared others who were not taking it.
Yep, the South Korean study isn't the only one whose statistical results don't even come close to matching the NEJM study, who is lying? These Indian and South Korean researchers or those involved in the NEJM publication again, for the umpteenth time? The results are supposed to at least somewhat match up if all publications are reflective of the reality of the matter (whether HCQ works or not). We're all talking post-exposure prophylaxis here, why does it work in India and South Korea but not in the US, supposedly (if you have to believe these results)?
JoshticeMed
Just skimming it I don't think it was possible to assess the question with the study design and sample size. Only 2 severe cases/hospitalizations in entire study (1 in each group)
Yep, brought that up as well, focusing on 1 of those 2 (the one in the HCQ group, who I like to see on camera to do his/her testimony).
Hakim Dehbi
absence of evidence isn't evidence of absence. When you say "... shows a lack of efficacy", you're falling into this trap. The CI is from - 2 to 7%. This is large and include potentially very large treatment effect (as well as harm), because of a small sample size.
All relevant remarks before blindly going along with the news article titles I earlier referred to. That love to jump the gun on this one, cause they've got their precious so-called "randomized double-blinded controlled trial" to wave up in the air as if showing off their excellent report card to their parents. The type I earlier described as being better 'dressed up' than the VA study, but is just more of the same (less recognizable for what it is because of being better dressed up as a 'scientific gem of integrity' compared to the VA study).
PSK
Some scientists and doctors must have spent more time in proving ineffectiveness (by hook or by crook) of hydroxychloroquine- then anything good about it. ...
Sad, but true.
Oh, earlier I talked about my biggest gripe with this study, but my biggest gripe is actually that it doesn't match up with the other studies concerning HCQ used as post-exposure-prophylaxis, such as the South Korean one with very similar numbers of participants taking HCQ following the protocol completely (312 vs 205 if comparing the NEJM with the South Korean one, linked on the previous page of this thread under the title "Can Post-Exposure Prophylaxis for COVID-19 Be Considered as an Outbreak Response Strategy in Long-Term Care Hospitals? - PubMed"). So either this NEJM publication is giving a false impression, or the other ones that do attribute efficacy to HCQ in this regards are, such as the South Korean one. They can't both (or all if you include other positive reports about HCQ working as a prophylaxis) be reflecting the truth of the matter, one must give a false impression. I know where my money is on, the one with the clearest motive for giving a false impression and a history of promoting a false impression about HCQ. The one that doesn't emphasize the need for actual positive PCR tests before padding the numbers of "probable" infections, an irrelevant number for accurate reliable statistical analysis, but wonderful for manipulation, bias and marketing purposes.
The other aspect of that gripe is that I already expected such negative publications about HCQ based on motive and for marketing purposes. Making me even more skeptical cause I'm not supposed to know the results ahead of time, unless I'm right about their willingness to fudge the numbers to show what they want them to show, and their ability to do that while still maintaining that appearance of a gold standard clinical trial, honest research and science and scientific integrity.
originally posted by: Grimpachi
a reply to: whereislogic
...
You keep bringing up that Trump used HCQ like it means something. ...
originally posted by: Grimpachi
a reply to: whereislogic
...
And for the record, the original post you responded to with insults showed the article link and pertinent info within. I didn't add any exposition to it denouncing or praising the info. Maybe try it sometime. I bet more people will read it instead of skimming or skipping over the bulk of your posts then.